Global markets: A mixed week… - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Global markets: A mixed week…

Dec 18, 2004

The US markets closed this week on a positive note amidst rising crude prices and negative news announcement on the corporate side, especially from the major pharma companies. We take a closer look at the performance of the same as well as that of Indian ADRs during the week. ADR action…
As is evident from the table below, MTNL was the major gainer during the week. The stock has been gaining ground off late on the back of merger talks with BSNL, the other pan-Indian state-owned telecom major with an estimated market share of more than 90% in the fixed telephony segment. Since MTNL has the license to provide telecom services in Mumbai and Delhi only, where penetration levels are the highest, growth prospects are limited. With the advent of increased competition, it is losing out its standing on the fixed telephony segment as well. While MTNL’s initiatives on the mobile telephony segment have been encouraging, consistency is lacking, which has impacted financial performance. Also, while cash flows continue to remain strong, growth is difficult to come by. But investors seem to be lapping up the share in anticipation of the merger, which is uncertain for now. On the other hand, Rediff and Sify, the two leading Internet portals in the country were among the key losers after gaining ground the week ended December 10 2004.

ADR 13th Dec'04 17th Dec'04 Change
Rediff 9.5 8.5 -10.8%
Sify 6.3 6.1 -2.7%
Satyam Computers 24.1 24.0 -0.4%
ICICI Bank 19.2 19.5 1.7%
Dr. Reddy 18.6 19.1 2.9%
Infosys 67.5 69.5 2.9%
Wipro 24.2 25.0 3.3%
HDFC Bank 38.9 40.3 3.6%
Tata Motors 10.9 11.3 4.0%
VSNL 9.6 10.0 4.2%
MTNL 7.2 7.9 8.6%

US economy…
The key event of the week was the Federal Reserve meeting, following which the federal fund rate was increased by yet another 25 basis points. Following this hike, the US interest rates have gone up by 125 basis points (1.25%) in the past one-year. The statement by the Federal Reserve Governors reads, "The Committee perceives the upside and downside risks to the attainment of both sustainable growth and price stability for the next few quarters to be roughly equal. With underlying inflation expected to be relatively low, the Committee believes that policy accommodation can be removed at a pace that is likely to be measured." It is widely expected that the ‘measured’ stance will mean that the upward trend in federal fund rate is likely to continue in the next calendar year as well.

Besides economic performance, two important announcements from Pfizer and Merck shook the markets. Pfizer’s announcement with regard to its drug ‘Cerebrex’ (estimated sales of US$ 2.5 bn in the US market) and Merck’s fallout of the ‘Vioxx’ pullout continues to have an impact on investor sentiment. After weakening for most of the first half of the December, crude prices hardened on the back of production cuts announcement by the OPEC and concerns with regard to the inventory levels in the US.


Equitymaster requests your view! Post a comment on "Global markets: A mixed week…". Click here!

  

More Views on News

Better Days Ahead for the Markets (Fast Profits Daily)

Oct 22, 2020

Commodity prices are signalling an economic recovery.

Will Blackstone Group Manage L&T Mutual Fund's Assets Successfully? (Outside View)

Oct 22, 2020

PersonalFN explains whether Blackstone will be able to successfully manage L&T mutual fund's assets in the event of a potential acquisition.

Your "I Was There" Moment in History Could Be Today...Don't Miss It (Profit Hunter)

Oct 22, 2020

The last time such a moment showed up in history, few investors grabbed a 65 bagger.

An Update for Those Looking to Trade Crude Oil and Natural Gas (Fast Profits Daily)

Oct 21, 2020

Trading crude oil and natural gas in the near future will be challenging. Here's why...

Will Pharma and Healthcare Funds Improve the Health of Your Portfolio? (Outside View)

Oct 21, 2020

The COVID-19 pandemic has turned to be a high-growth opportunity for India's Pharma and Healthcare Sector.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

One of the Best Investment Opportunities in the Market Right Now (Fast Profits Daily)

Oct 16, 2020

The one sector that you should be looking at to make good profits.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Oct 22, 2020 03:36 PM

MARKET STATS